null Matthew Jenkin
Matthew Jenkin

Matthew Jenkin

Senior Research Analyst

  • 11 Years with the firm
  • 27 Years of industry experience

Matt is a senior research analyst covering the Health Care sector, specifically biopharmaceutical and medical technology companies, and a portfolio manager on the Smart Cures Innovation strategy. Prior to joining the firm, Matt has served as a Health Care portfolio manager and analyst at Balyasny Asset Management. Prior to that, he managed global long/short equity health care hedge funds and covered the pharmaceuticals, biotechnology and health care services industries at Lehman Brothers/Barclays Capital. Previously, he initiated and managed the Dreyfus Health Care Fund and was an analyst covering the Health Care sector. He has been in the investment industry since 2000.

Prior to joining the investment industry, Matt was a senior research scientist at SmithKline Beecham, where he helped to develop cardiovascular/general surgical techniques, designed surgical models for MRI in stroke research, and researched osteoporosis.

Matt earned a bachelor's degree in biology from Tulane University and an MBA from New York University.

Experience listed may include partial year periods.